Atnaujinkite slapukų nuostatas

El. knyga: Antiarrhythmic Drugs

Edited by , Edited by , Edited by
  • Formatas: PDF+DRM
  • Išleidimo metai: 17-Feb-2025
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783031740466
  • Formatas: PDF+DRM
  • Išleidimo metai: 17-Feb-2025
  • Leidėjas: Springer International Publishing AG
  • Kalba: eng
  • ISBN-13: 9783031740466

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

This extensively updated edition reviews current and potential future therapies for cardiac arrhythmias. Developing the highly practical format of the original, this edition provides a thorough guide for the use of pharmaceuticals in the management of the condition and is focused on providing a clinical manual for arrhythmia treatment.

Antiarrhythmic Drugs builds on the current understanding of pathophysiological mechanisms and insights gained from previous studies of therapeutic interventions. It is designed to establish the baseline level of knowledge that a cardiovascular professional needs to know on a day-to-day basis.

Introduction: Cardiac arrhythmias a clinical problem.- Electrophysiological basis of the arrhythmias.- Class I antiarrhythmic drugs (Na+ channel blockers).- Potassium-channel blockers.- Betablockers.- Modulation of calcium handling/Calcium-channel modulators.- Other antiarrhythmic drugs: Novel targets for AADs.- Non-antiarrhythmic drugs with antiarrhythmic effects.- Clinical management of the arrhythmias.
A Martinez Rubio, is Chief of the Cardiology Department at the University Hospital of Sabadell and professor of Medicine at the Universitat Autņnoma of Barcelona, Spain. Ex-president of the International Society of Cardiovascular Pharmacotherapy









J Tamargo is professor of Pharmacology at the School of Medicine of the Univ. Complutense of Madrid, Spain





 





G.-Andrei Dan is Distinguished/Emeritus Professor of Cardiology & Internal Medicine  at the Carol Davila University of Medicine,  Honorary Member of the Romanian Academy of Scientists and past President of ISCP. Profesor Dan' main expertise is electrophysiology, pharmacology of antiarrhythmic drugs, atrial fibrillation and heart failure. He wrote more than 170 scientific papers, presented more than 50 international conferences and contributed to 15 European guidelines. He is a member of the board of several prestigious medical journals, Deputy Editor of the American Journal of Therapeutics and Editor in Chief of the Romanian Journal of Internal Medicine. He is also an Honorary Citizen of the Romanian capital, Bucharest